Biodesix Inc
BDSX- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001439725
In the last 90 days, Biodesix Inc insiders filed 2 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Biodesix Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 60 | 41 | −19 |
| Shares | 53.4M | 35.6M | −17.8M (−33.3%) |
| Value | $33.4M | $10.0M | −$23.3M (−69.9%) |
New holders (6)
Institutions that held Biodesix Inc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 859,524 | $242.6K | 0.00% |
| Nantahala Capital Management, LLC | 84,903 | $24.0K | 0.00% |
| JustInvest LLC | 41,909 | $11.8K | 0.00% |
| Cubist Systematic Strategies, LLC | 14,346 | $4.05K | 0.00% |
| Carnegie Capital Asset Management, LLC | 10,000 | $2.82K | 0.00% |
| Cetera Investment Advisers | 10,000 | $2.82K | 0.00% |
Sold out (25)
Institutions that held Biodesix Inc at the end of Q1 2025 and filed for Q2 2025 without it.